TECH - Bio-Techne Corp
(NaN%)
SNP 500
Sell
Moderate Growth but Declining●Stock Price Very High
56%
based on last 5 year data.
Income Statement is MODERATE
Revenue Growth is 2.41%
Operating Income Growth is -36.07%
Net Income Growth is -38.91%
Earnings Per Share (EPS) Growth is -37.09%
Net Margin is 12.86%
Balance Sheet is STRONG
Current Asset to Current Liability Ratio is 4.56
Debt Ratio is 0.06
Current Debt to Net Income Ratio is 0.0
Total Debt to Total Assets Ratio is 0.11
Cash Flow is MODERATE
Cash from Operations Growth is 17.77%
Capital Expenditure is High
Net Increase in Cash is Positive
Long Term Score Trend is NEGATIVE
Investment Risk is High
based on last 4 quarter data.
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Bio-Techne Corp (TECH) - https://www.bio-techne.com/
bio-techne (formerly techne corp.), nasdaq: tech, is a global life sciences company providing innovative bioactive tools and resources for the research and clinical diagnostic communities. bio-techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. they aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. with over 275,000 products in its portfolio, bio-techne generated approximately $358 million in net sales in fy 2014 and has over 1,000 employees worldwide.Exchange - NASDAQ
Industry - Biological Product (except Diagnostic) Manufacturing
Sector - Manufacturing
CEO - Charles Kummeth
Employees - 1,595
Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2024 and future.
Know the Stock © 2024 and future.